An observational study in Stroke, sponsored by Hacettepe University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 30 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-20.
Sponsored by Hacettepe University · Observational
Latissimus Dorsi (LD); Medial sacrum, lumbar vertebrae and lower thoracic vertebrae 10-12 lateral to the spinous processus. It is a fan-like wide muscle that connects to the inferior angle of the scapula and ribs, adheres to the anterior surface of the proximal humerus and continues with aponeurosis of the contralateral Gluteus Maximus below. The activation of the LD muscle during the functional reach activity, which we use most frequently in daily living activities, affects the upper extremity and trunk movements. Therefore it is important muscle that affects the quality of movement.
The study include individuals with stroke that diagnosed by the neurologist and include healthy subjects. During sitting activity, they will be required to reach three different distances in the sagittal and scapular plane: arm length, 125% of the arm length and end point where it can reach the modified functional reach test. During the activity, electromyography (EMG) activation of latissimus dorsi, anterior deltoid and erector spina muscles will be examined with electromyographic device.
Hypothesis originating from the investigation:
H1: Latissimus dorsi muscle segments show different activation during functional reach activity.
H2: Activation of latissimus dorsi muscle segments is affected by reaching direction during functional reach activity.
H3: Activation of latissimus dorsi muscle segments is affected by reaching distance during functional reach activity.
Measurements will be made during the sitting activity of the individuals included in the study. Individuals will be asked to reach midsternal height cups in two separate planes, sagittal and scapular, at arm's end, 125% of arm's distance and end point where it can reach according to modified functional reach test.
Muscle activation of latissimus dorsi, erector spina and anterior deltoid muscles will be measured by superficial electromyographic measurement. Muscle activation according to SENIAM for erector spina and anterior deltoid will be evaluated. For latissimus dorsi, activation will be measured in six segments separated according to anatomic dissection.
Reach activity will be performed 3 times on each side and at 1 minute intervals.
7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.
This study's enrollment of 12 is below the median of 160 across 1,729 observational studies indexed under Stroke.
Browse Stroke studies →Hacettepe University is the lead sponsor of 1,001 studies on the registry; 215 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Hacettepe University Neurological Rehabilitation Unit
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Electromyographic device
Other: Electromyographic device
An 8-channel surface EMG system (Noraxon Telemyo DTS system, Scottsdale, USA) will be used to measure signals from muscles during surface electromyography measurements.
Surface electromyographic measurement
Muscle activation measurement It is an 8-channel system for measuring signals come from muscles (Noraxon Telemyo DTS system, Scottsdale, USA).
Time frame: 90 minutes
Plan to share: No
This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.